NCT02478892Recruiting
Preliminary Evaluation of Screening for Pancreatic Cancer in Patients With Inherited Genetic Risk
Source: ClinicalTrials.gov · Last updated 5 Feb 2026
Brief summary (registry, in English)
The study is a prospective, observational study evaluating the utility of endoscopic ultrasound or MRI for the identification of preneoplastic and neoplastic pancreatic lesions in patients at high risk for pancreatic cancer, specifically those with BRCA1/2, ATM, or PALB2 mutations.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 19 Jun 2015
- Start date
- May 2015
- Primary completion date
- May 2028
- Lead sponsor
- Abramson Cancer Center at Penn Medicine
- Diseases
- Pancreatic cancer
- NCT number
- NCT02478892
What you commit to
- Study type: Observational
- Planned participants: 200
- From May 2015 to the primary completion date, May 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Pregnancy
Who the study is looking for
- Age \>= 18
- Documented germline pathogenic or likely pathogenic BRCA1, BRCA2, ATM, or PALB2 mutation
- If no history of PDAC in a first or second degree relative, age \>= 50
- If there is a history of PDAC in a first or second degree relative, minimum age of eligibility is 10 years younger than the age of onset of the youngest relative with pancreatic cancer
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Abramson Cancer Center of the University of Pennsylvania Coordinator of this site? Confirm its status | Philadelphia | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.